OneChain Immunotherapeutics
Laura Rodríguez Gallego is an experienced professional in the biotechnology sector, currently serving as a board member and observer for multiple companies, including EsoBiotec, Telomere Therapeutics, OneChain Immunotherapeutics, and Gyala Therapeutics. With a strong background in investment and advisory roles at Invivo Partners and Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré, Laura has held positions ranging from investment analyst to partner since March 2019. Academic credentials include a PhD in Biotechnology and a Master's in Molecular Biotechnology from Universitat de Barcelona, complemented by a Bachelor's degree in Biotechnology from Universitat Autònoma de Barcelona.
This person is not in the org chart
This person is not in any teams
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.